Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
06/2003
06/04/2003EP1315800A2 Human proteases
06/04/2003EP1315793A1 Methods for culturing human lung mast cells and uses thereof
06/04/2003EP1315758A2 Methods and reagents for protease inhibition
06/04/2003EP1315746A1 Codon optimised recombinant dermaphagoides allergens
06/04/2003EP1315742A1 Amino acid substitution mutants of interleukin 13
06/04/2003EP1315741A2 A method for treating allergies
06/04/2003EP1315735A1 Phosphate derivatives as immunoregulatory agents
06/04/2003EP1315727A2 7-oxo pyridopyrimidines
06/04/2003EP1315726A1 7- oxo pyridopyrimidines as inhibitors of cellular proliferation
06/04/2003EP1315720A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315718A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315717A1 Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315716A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315705A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315694A2 Inhibitors of alpha 4 mediated cell adhesion
06/04/2003EP1315513A2 "pseudo"-native chemical ligation
06/04/2003EP1315511A2 Synthetic erythropoiesis stimulating proteins
06/04/2003EP1315504A1 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications
06/04/2003EP1315496A2 The treatment of inflammatory disorders
06/04/2003EP1315476A2 Nitric oxide-producing hydrogel materials
06/04/2003EP1315475A1 Lung surfactant compositions with dynamic swelling behaviour
06/04/2003EP1216046B1 Novel combination of loteprednol and antihistamines
06/04/2003EP1198224B1 Formulations of steroid solutions for inhalatory administration
06/04/2003EP1156790B1 Combinations of formoterol and mometasone furoate
06/04/2003EP1143928B1 Milling process for the production of finely milled medicinal substances
06/04/2003EP1140945B1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
06/04/2003EP1075476B1 Novel benzimidazoles and benzoxazoles
06/04/2003EP0944616B1 Bicyclic aryl carboxamides and their therapeutic use
06/04/2003EP0927031B1 Pharmaceutical preparation containing nimesulide for oral administration
06/04/2003CN1422273A 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases
06/04/2003CN1422271A Pyrrolopyrimidinone derivatives, process of preparation and use
06/04/2003CN1422270A Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines
06/04/2003CN1422269A 1H-imidazopyridine derivatives
06/04/2003CN1422263A Estrogen agonist/antagonist metabolites
06/04/2003CN1422262A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
06/04/2003CN1422260A 2-guanidino-4-arylchinazolines as NHE-3 inhibitors
06/04/2003CN1422162A Composition and method for treating allergic and inflammatory conditions with cough containing a non-sedating histamine and an expectorant
06/04/2003CN1422154A The treatment of respiratory diseases
06/04/2003CN1421240A Chinese medicine prepn for treating throat diseases and stomatopathy and its prepn process
06/04/2003CN1421238A Natural bioreaction regulator with the functions of resisting cancer, resisting free radical damage and regulating immunity
06/04/2003CN1421217A Cough-relieving medicine
06/04/2003CN1421211A Cell growth regulating factor M and its prepn process
06/04/2003CN1110495C Arylalkyl diazinones, its preparing method and its medical preparation
06/04/2003CN1110488C 2-(3H)-oxazolene derivatives and their use as cox-2 inhibitors
06/04/2003CN1110484C 2-(cary lphenyl) amino-imidazoline derivatives
06/04/2003CN1110482C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
06/03/2003US6573364 Isolation and characterization of Hermansky Pudlak Syndrome (HPS) protein complexes and HPS protein-interacting proteins
06/03/2003US6573278 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
06/03/2003US6573273 Urea substituted imidazoquinolines
06/03/2003US6573270 Endothelin receptor antagonists
06/03/2003US6573255 Vitamin D analogues
06/03/2003US6573241 Therapeutic agent for the suppression of snoring noises
06/03/2003US6573100 DNA vectors without a selection marker gene
06/03/2003US6573093 Temperature sensitive plasmids of P. haemolytica
06/03/2003US6573073 Oligonucleotide regulatory sequence that increases promoter activity; vectors; gene therapy for cystic fibrosis; cystic fibrosis transmembrane conductance regulator (CFTR)
06/03/2003US6573066 FtsH from Staphylococcus aureus
06/03/2003US6572861 Lecithin, oil in water emulsion and an amphiphilic surfactant; minimize local reactions to the vaccine
06/03/2003US6572858 Uses for anti-malarial therapeutic agents
06/03/2003CA2273446C Piperidones
06/03/2003CA2047858C (quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
05/2003
05/30/2003WO2003044182A1 CELLS EXPRESSING gob-5 AND USE THEREOF
05/30/2003WO2003044170A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003WO2003044162A2 Genes encoding g-protein coupled receptors and methods of use therefor
05/30/2003WO2003044021A2 Substituted indolizine-like compounds and methods of use
05/30/2003WO2003044010A1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity
05/30/2003WO2003044009A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003044006A1 Substituted benzopyrans as selective estrogen receptor-beta agonists
05/30/2003WO2003043988A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
05/30/2003WO2003043986A1 Polypeptides of moraxella (branhamella) catarrhalis
05/30/2003WO2003043985A1 Heterocyclic compounds and methods of use
05/30/2003WO2003043981A1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
05/30/2003WO2003043980A1 Azetidinyl diamines useful as ligands of the nociceptin receptor orl-1
05/30/2003WO2003043905A2 Pharmaceutical product with an adsorbent
05/30/2003WO2003043650A1 Use of fk506 and analogues for treating allergic diseases
05/30/2003WO2003043639A2 PHARMACEUTICAL COMPOSITION COMPRISING A ClC-2 CHANNEL OPENER
05/30/2003WO2003043636A1 Nicotin-or isonicotin benzothiazole derivatives
05/30/2003WO2003043634A1 Benzothiazole derivatives as adenosine receptor ligands
05/30/2003WO2003043627A1 New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma
05/30/2003WO2003043625A1 2-aryl-propionic acids and pharmaceutical compositions containing them
05/30/2003WO2003043621A1 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes
05/30/2003WO2003043619A1 New use for the treatment of gastroesophageal reflux disease
05/30/2003WO2003043614A2 Reversible proton pump inhibitors for the treatment of airway disorders
05/30/2003WO2003043612A1 Micronized film-forming powder comprising an active substance
05/30/2003WO2003043583A2 Treatment of immunological disorders using anti-cd30 antibodies
05/30/2003WO2003043572A2 Methods and compositions related to irm compounds and toll-like receptor pathways
05/30/2003WO2003027248A3 Antibody inhibitors of gdf-8 and uses thereof
05/30/2003WO2003002106A3 Use of tyrosine kinase inhibitions for treating allergic diseases
05/30/2003WO2002100890A3 Respiratory syncytial virus
05/30/2003WO2002096952A3 Conjugate of a transport protein and a protein for modulation of notch signalling
05/30/2003WO2002096363A3 Method for treating fibrotic diseases or other indications
05/30/2003WO2002070509A3 Antagonists of mcp-1 function and methods of use thereof
05/30/2003WO2002067967A3 Method of treating rhinitis or sinusitis
05/30/2003WO2002066040A3 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
05/30/2003WO2002036816A3 Method of determining susceptibility to diseases
05/30/2003WO2002016313A3 Integrin receptor inhibitors
05/30/2003WO2002000692A9 Pd-l2 molecules: pd-1 ligands and uses therefor
05/30/2003CA2503669A1 New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma
05/30/2003CA2468018A1 Micronized film-forming powder comprising an active substance
05/30/2003CA2467752A1 Piperidin-2-one derivative compounds and pharmaceutical composition comprising the same as active ingredient
05/30/2003CA2467652A1 Reversible proton pump inhibitors for the treatment of airway disorders
1 ... 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 ... 878